A key aim of GERA is to transfer our research insights and outcomes into practice and decision-making by working with stakeholders such as researchers, clinicians, governments and policy makers.
Learn about our findings and collaborations at the channels below. You may also find our Latest News, eNews and LinkedIn of interest.
2026
- Yang R, MacInnis RJ, Milne RL, Nguyen-Dumont T, Maxwell WF, Genkinger JM, Glendon G; Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer (kConFab); Ross EA, Andrulis IL, Colonna SV, Daly M, John EM, Kurian AW, Terry MB, Hopper JL, Southey MC, Phillips KA, Li S. Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study. BMC Med. 2026 Mar 4. doi: 10.1186/s12916-026-04753-8. Epub ahead of print. PMID: 41776557.
- Ye Z, Xu R, Malone GL, Dugué PA, Nguyen TL, Giles GG, Southey MC, Milne RL, Li S. Genome-wide analysis highlights epigenetic link to age at menarche. Hum Reprod. 2026 Feb 23:deag019. doi: 10.1093/humrep/deag019. Epub ahead of print. PMID: 41729831.
2025
- Li S, Madanat-Harjuoja L, Leslie G, Barnes DR, Bolla MK, Dennis J, Parsons MT, Apostolou P, Arnold N, Bosse K; EMBRACE Collaborators; Cook J, Engel C, Evans DG, Fostira F, Frone MN, Gehrig A, Greene MH, Hackmann K, Hahnen E, Harbeck N, Hauke J, Hentschel J, Horvath J, Izatt L, Kiechle M, Konstantopoulou I, Lalloo F, Ngeow J, Niederacher D, Ritter J, Santamariña M, Schmutzler RK, Searle C, Sutter C, Tischkowitz M, Tripathi V, Vega A, Wallaschek H, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Zhao E, Easton DF, Antoniou AC, Chenevix-Trench G, Rebbeck TR, Diller LR. Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers. J Natl Cancer Inst. 2025 Apr 1;117(4):728-736. doi: 10.1093/jnci/djae306. PMID: 39585318; PMCID: PMC11972678.
- Li C, Dite GS, Nguyen TL, Hopper JL, Li S. Cancer incidence inconsistency between UK Biobank participants and the population: a prospective cohort study. BMC Med. 2025 Mar 26;23(1):181. doi: 10.1186/s12916-025-03998-z. PMID: 40140825; PMCID: PMC11948887.
2024
- Li S, Dite GS, MacInnis RJ, Bui M, Nguyen TL, Esser VFC, Ye Z, Dowty JG, Makalic E, Sung J, Giles GG, Southey MC, Hopper JL. Causation and familial confounding as explanations for the associations of polygenic risk scores with breast cancer: Evidence from innovative ICE FALCON and ICE CRISTAL analyses. Genet Epidemiol. 2024 Dec;48(8):401-413. doi: 10.1002/gepi.22556. Epub 2024 Mar 12. PMID: 38472646; PMCID: PMC11588973.
- Li S, Hopper JL. Breast Cancer Risk for Women With a TP53 Pathogenic Variant. JCO Precis Oncol. 2024 May;8:e2400166. doi: 10.1200/PO.24.00166. PMID: 38820492.
- Hopper JL, Li S, MacInnis RJ, Dowty JG, Nguyen TL, Bui M, Dite GS, Esser VFC, Ye Z, Makalic E, Schmidt DF, Goudey B, Alpen K, Kapuscinski M, Win AK, Dugué PA, Milne RL, Jayasekara H, Brooks JD, Malta S, Calais-Ferreira L, Campbell AC, Young JT, Nguyen-Dumont T, Sung J, Giles GG, Buchanan D, Winship I, Terry MB, Southey MC, Jenkins MA. Breast and bowel cancers diagnosed in people ‘too young to have cancer’: A blueprint for research using family and twin studies. Genet Epidemiol. 2024 Dec;48(8):433-447. doi: 10.1002/gepi.22555. Epub 2024 Mar 19. PMID: 38504141; PMCID: PMC11589006.
- Ye Z, Dite GS, Nguyen TL, MacInnis RJ, Schmidt DF, Makalic E, Al-Qershi OM, Nguyen-Dumont T, Goudey B, Stone J, Dowty JG, Giles GG, Southey MC, Hopper JL, Li S. Genetic and Environmental Causes of Variation in an Automated Breast Cancer Risk Factor Based on Mammographic Textures. Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):306-313. doi: 10.1158/1055-9965.EPI-23-1012. PMID: 38059829.
Presentations:
- Population-based cancer risk estimates for pathogenic variants in breast cancer high-risk genes
Presentation at The 2nd Australian UKB Research Symposium, 9-13 February 2026, Brisbane, Australia.
Yiping Wang - Cancer risks associated with ATM pathogenic variants.
Presentation at Familial Aspects of Cancer Research and Practice 2024, Kingscliff, Australia.
Shuai Li
Posters:
- Association between CHIP-status and epigenetic markers of aging with time
Poster at GeneMappers 2026, Manly, NSW, Australia
Robert O’Reilly - Genetic Susceptibility and Causes of Early-Onset Breast Cancer
Poster at GeneMappers 2026, Manly, NSW, Australia
Shuhan Peng - Genetic Epidemiology Research Alliance: A Centre of Research Excellence to Advance Precision Population Health.
Poster and Online Presentation at Familial Aspects of Cancer Research and Practice 2024, Kingscliff, Australia.
Jessica Tyler - Cancer Risk for Carriers of BRCA1 or BRCA2 Pathogenic Variants: A Prospective Study.
Poster at Familial Aspects of Cancer Research and Practice 2024, Kingscliff, Australia.
Ruotong Yang
- Pinpointing risk – Breast cancer fine mapping
A/Prof Kyriaki Michailidou, Biostatistics Unit Lead at the Cyprus Institute of Neurology and Genetics
Victorian Comprehensive Cancer Centre (VCCC) Alliance Webinar Series, 25 August 2025 – Recording - How much heritability are we still missing?
A/Prof Loic Yengo, University of Queensland
Genomics Interest Group, 28 March 2025 – Recording - The Genomics of Health and Disease: Lessons from the Old and Very Young
Dr Mark Pinese, Children’s Cancer Institute, NSW.
Genomics Interest Group, 23 May 2025 – Recording - Leveraging Tasmania’s unique genealogy to identify rare cancer risk genes
A/Prof Liesel FitzGerald , University of Tasmania
Genomics Interest Group, 19 September 2025 – Recording - Multiomics Meets Reality: Challenges in Validating Mesothelioma Treatment Response
Dr Melvin Chin, Sir Charles Gairdner Hospital, WA
Genomics Interest Group, 28 November 2025 – Recording
- Two health Centres of Research Excellence announced by NHMRC. University of Melbourne
- NeuRA to be part of new NHMRC-funded Centre of Research Excellence. Neuroscience Research Australia
- Daffodil Centre researchers celebrate NHMRC Centre’s of Research Excellence collaboration success. Daffodil Centre